4694 — BML Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapSuper Stock

Annual income statement for BML, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	186,067	159,462	137,964	143,191	150,262
Cost of Revenue
Gross Profit	86,951	61,446	45,629	45,862	48,690
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	137,932	135,739	128,884	134,126	140,069
Operating Profit	48,135	23,723	9,080	9,065	10,193
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	50,328	24,184	9,523	9,673	11,987
Provision for Income Taxes
Net Income After Taxes	34,678	16,157	6,263	6,509	8,010
Minority Interest
Net Income Before Extraordinary Items
Net Income	33,741	15,579	6,035	6,264	7,749
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	33,741	15,578	6,034	6,263	7,748
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	845	399	156	166	186
Dividends per Share
Special Dividends per Share